Abstract
After 7 years leading Merck Research Laboratories, Roger Perlmutter will retire at the end of 2020. Under his leadership, Merck has achieved some 100 regulatory approvals for treatments, including medicines for cancer and diabetes. Perlmutter will be succeeded by Dean Li, currently head of discovery sciences and translational medicine. And after 8 years at Sanofi, Chief Scientific Officer Gary Nabel is leaving. His replacement is Frank Nestle, who was named head of Sanofi’s immunology and inflammation programs this summer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
